We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patent Thickets Won’t Be Stopped Until FDA and USPTO Collaborate Better, Say Senators and Experts
Patent Thickets Won’t Be Stopped Until FDA and USPTO Collaborate Better, Say Senators and Experts
Congress needs to put more pressure on agencies like the FDA and the US Patent and Trademark Office (USPTO) to collaborate on fighting patent thickets, the multiple patents pharmaceutical companies file after a drug is already on the market to extend the drug’s period of exclusivity and keep generic alternatives off the market.